Evaluating Effects of EPO in Rodent Behavioral Assays Related to Depression
互联网
444
The cytokine erythropoietin (EPO) is an important regulator of hematopoesis and has well-known tissue protective properties.
Neurotrophic action is implicated as mechanistically important in the treatment of depression, and neurotrophic actions of
EPO suggest potential therapeutic utility of an EPO-like mechanism in depressive disorder. Rodent behavioral models that are
responsive to clinically used antidepressants as well as to neurotrophic compounds can be used to assess potential antidepressant
properties of EPO and EPO-like compounds. Rodent models described here are the forced-swim test (FST), a hyponeophagia test
and the novel object recognition test. Each of these models provides different information and relevance to depression and
each can be tested with EPO and similar compounds.
